Differentiation of infiltrative cardiomyopathy from hypertrophic cardiomyopathy using high-sensitivity cardiac troponin T: a case-control study

Table 2 Echocardiographic findings in 46 patients with cardiomyopathy

	Infiltrative cardiomyopathy (n = 11)	HCM (n = 35)	p value
Maximum LV wall thickness, mm	17 ± 3	20 ± 4	0.021
Interventricular wall thickness, mm	16 ± 3	16 ± 4	0.628
Posterior wall thickness*, mm	15 ± 3	11 ± 2	<0.001
LV end-diastolic diameter*, mm	44 ± 5	44 ± 6	0.836
LV end-systolic diameter*, mm	32 ± 7	28 ± 7	0.118
Ejection fraction*, %	54 ± 13	62 ± 13	0.104
Left atrial diameter, mm	44 ± 6	43 ± 8	0.723
E*, cm/s	89 ± 23	69 ± 21	0.012
A, cm/s	67 ± 33	64 ± 19	0.704
E/A*	1.7 ± 1.0	1.1 ± 0.5	0.141
Dct*, msec	208 ± 81	200 ± 68	0.857
Ea septal*, cm/s	3.9 ± 1.1	5.2 ± 2.3	0.116
Ea lateral*, cm/s	4.8 ± 1.3	8.1 ± 3.5	<0.001
E/Ea septal	24 ± 7	15 ± 7	<0.001
E/Ea lateral*	20 ± 8	10 ± 4	<0.001
Presence of LVOTO, n (%)	1 (9 %)	7 (20 %)	0.658
Presence of RVH, n (%)	6 (55 %)	18 (51 %)	0.857

Data are shown as mean ± SD or number (percent)
A mark of * is the results of Wilcoxon rank sum test
HCM Hypertrophic cardiomyopathy, LV Left ventricular, LVOTO Left ventricular outflow tract obstruction, RVH Right ventricular hypertrophy

ISSN: 1471-2261